サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1239490

尿管鏡検査市場：製品別、用途別、エンドユーザー別：世界の機会分析と産業予測、2021-2031年

Ureteroscopy Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031
出版日: | 発行: Allied Market Research | ページ情報: 英文 210 Pages | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
尿管鏡検査市場：製品別、用途別、エンドユーザー別：世界の機会分析と産業予測、2021-2031年
出版日: 2023年01月01日
発行: Allied Market Research
ページ情報: 英文 210 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の尿管鏡検査市場は、2021年に8億734万米ドルと評価され、2022年から2031年にかけて5.5%のCAGRを記録して、2031年には13億7,982万米ドルに達すると予測されます。

尿管鏡検査は、さまざまな尿路の問題を診断し治療するために用いられる手順です。小さなスコープ（軟性望遠鏡のようなもの）を膀胱と尿管に導入します。尿管鏡検査は上部尿路の検査で、尿道と膀胱を通過した後、尿管に直接挿入する尿管鏡で行われます。この検査は、腎臓結石や上部尿路の尿路上皮がんなどの診断と治療に有用です。手術には通常1～3時間かかり、患者が全身麻酔をかけた状態で行われるのが一般的です。

世界の尿管鏡検査市場の成長は、技術の進歩や、尿管鏡検査装置を必要とする腎臓がんや腎臓結石などの泌尿器疾患の有病率の増加が、市場成長を後押しする主要な要因となっています。さらに、インドや中国などの新興国市場における医療需要の増加や新興国市場での成長機会は、予測期間中に尿管鏡検査市場に膨大な機会をもたらすと期待されています。

しかし、尿管鏡に関連する高コストが市場の成長を妨げています。さらに、尿管鏡の臨床的障壁と感染リスクは、世界の尿管鏡市場の主要な抑制要因として作用します。一方、中国やインドなどの国々では、医療費の増加や専門病院・クリニックの増加により、市場の成長に有利な機会が生まれると期待されています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な影響要因
    • 主な投資ポケット
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威が高い
    • 新規参入業者の脅威が高い
    • 適度な競争の激しさ
  • 市場力学
    • 促進要因
      • 泌尿器疾患の有病率の増加
      • 泌尿器科手術件数の増加
      • 尿管鏡の需要の増加
    • 抑制要因
      • 尿管鏡の副作用
      • デジタル尿管鏡の高コスト
    • 機会
      • 技術進歩の台頭
  • 市場におけるCOVID-19影響分析

第4章 尿管鏡検査市場：製品別

  • 概要
    • 市場規模と予測
  • 軟性尿管鏡
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 半剛性尿管鏡
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第5章 尿管鏡検査市場：用途別

  • 概要
    • 市場規模と予測
  • 尿路結石症
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 腎がん
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 尿路狭窄
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第6章 尿管鏡検査市場：エンドユーザー別

  • 概要
    • 市場規模と予測
  • 病院
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • 外来手術センター
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測：地域別
    • 市場シェア分析： 国別

第7章 尿管鏡検査市場：地域別

  • 概要
    • 市場規模と予測：地域別
  • 北米
    • 主な動向と機会
    • 市場規模と予測：製品別
    • 市場規模と予測：用途別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • 米国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • カナダ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • メキシコ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
  • 欧州
    • 主な動向と機会
    • 市場規模と予測：製品別
    • 市場規模と予測：用途別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • ドイツ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • フランス
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • 英国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • イタリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • スペイン
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • その他欧州
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
  • アジア太平洋
    • 主な動向と機会
    • 市場規模と予測：製品別
    • 市場規模と予測：用途別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • 日本
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • 中国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • オーストラリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • インド
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • 韓国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • その他アジア太平洋地域
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
  • ラテンアメリカ・中東・アフリカ
    • 主な動向と機会
    • 市場規模と予測：製品別
    • 市場規模と予測：用途別
    • 市場規模と予測：エンドユーザー別
    • 市場規模と予測：国別
      • ブラジル
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • サウジアラビア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • 南アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別
      • その他のラテンアメリカ・中東・アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測：製品別
      • 市場規模と予測：用途別
      • 市場規模と予測：エンドユーザー別

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • トップ 10プレーヤーの製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トッププレーヤーのポジショニング、2021

第9章 企業プロファイル

  • Advin Health Care
  • Boston Scientific Corporation
  • Cliniva Healthcare
  • KARL STORZ SE & Co. KG
  • Olympus Corporation
  • OTU Medical
  • Hoya Corporation
  • Richard Wolf GmbH
  • STERIS plc
  • Stryker Corporation
図表

LIST OF TABLES

  • TABLE 01. GLOBAL URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. URETEROSCOPY MARKET FOR FLEXIBLE URETEROSCOPE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. URETEROSCOPY MARKET FOR SEMI- RIGID URETEROSCOPE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. URETEROSCOPY MARKET FOR UROLITHIASIS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. URETEROSCOPY MARKET FOR KIDNEY CANCER, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. URETEROSCOPY MARKET FOR URINARY STRICTURE, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. URETEROSCOPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. GLOBAL URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. URETEROSCOPY MARKET FOR HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. URETEROSCOPY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. URETEROSCOPY MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. URETEROSCOPY MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. NORTH AMERICA URETEROSCOPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. U.S. URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. CANADA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. MEXICO URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. MEXICO URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. EUROPE URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. EUROPE URETEROSCOPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. GERMANY URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. GERMANY URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. FRANCE URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. FRANCE URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. UK URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. UK URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. UK URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ITALY URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. ITALY URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. SPAIN URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. SPAIN URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. SPAIN URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. REST OF EUROPE URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. ASIA-PACIFIC URETEROSCOPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. JAPAN URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. JAPAN URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. CHINA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. CHINA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. AUSTRALIA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. AUSTRALIA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. AUSTRALIA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. INDIA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. INDIA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. INDIA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. SOUTH KOREA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. SOUTH KOREA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. SOUTH KOREA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LAMEA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. LAMEA URETEROSCOPY MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. BRAZIL URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. BRAZIL URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SAUDI ARABIA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SAUDI ARABIA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SOUTH AFRICA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SOUTH AFRICA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. REST OF LAMEA URETEROSCOPY MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA URETEROSCOPY MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. REST OF LAMEA URETEROSCOPY MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. ADVIN HEALTH CARE: KEY EXECUTIVES
  • TABLE 88. ADVIN HEALTH CARE: COMPANY SNAPSHOT
  • TABLE 89. ADVIN HEALTH CARE: PRODUCT SEGMENTS
  • TABLE 90. ADVIN HEALTH CARE: PRODUCT PORTFOLIO
  • TABLE 91. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 92. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 93. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
  • TABLE 94. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 95. CLINIVA HEALTHCARE: KEY EXECUTIVES
  • TABLE 96. CLINIVA HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 97. CLINIVA HEALTHCARE: PRODUCT SEGMENTS
  • TABLE 98. CLINIVA HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 99. KARL STORZ SE & CO. KG: KEY EXECUTIVES
  • TABLE 100. KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
  • TABLE 101. KARL STORZ SE & CO. KG: PRODUCT SEGMENTS
  • TABLE 102. KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
  • TABLE 103. OLYMPUS CORPORATION: KEY EXECUTIVES
  • TABLE 104. OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 105. OLYMPUS CORPORATION: PRODUCT SEGMENTS
  • TABLE 106. OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 107. OTU MEDICAL: KEY EXECUTIVES
  • TABLE 108. OTU MEDICAL: COMPANY SNAPSHOT
  • TABLE 109. OTU MEDICAL: PRODUCT SEGMENTS
  • TABLE 110. OTU MEDICAL: PRODUCT PORTFOLIO
  • TABLE 111. HOYA CORPORATION: KEY EXECUTIVES
  • TABLE 112. HOYA CORPORATION: COMPANY SNAPSHOT
  • TABLE 113. HOYA CORPORATION: PRODUCT SEGMENTS
  • TABLE 114. HOYA CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115. RICHARD WOLF GMBH: KEY EXECUTIVES
  • TABLE 116. RICHARD WOLF GMBH: COMPANY SNAPSHOT
  • TABLE 117. RICHARD WOLF GMBH: PRODUCT SEGMENTS
  • TABLE 118. RICHARD WOLF GMBH: PRODUCT PORTFOLIO
  • TABLE 119. STERIS PLC: KEY EXECUTIVES
  • TABLE 120. STERIS PLC: COMPANY SNAPSHOT
  • TABLE 121. STERIS PLC: PRODUCT SEGMENTS
  • TABLE 122. STERIS PLC: PRODUCT PORTFOLIO
  • TABLE 123. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 124. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 125. STRYKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 126. STRYKER CORPORATION: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. URETEROSCOPY MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF URETEROSCOPY MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN URETEROSCOPY MARKET (2022-2031)
  • FIGURE 04. HIGH BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. HIGH BARGAINING POWER OF BUYERS
  • FIGURE 06. HIGH THREAT OF SUBSTITUTES
  • FIGURE 07. HIGH THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALURETEROSCOPY MARKET
  • FIGURE 10. URETEROSCOPY MARKET, BY PRODUCT, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR FLEXIBLE URETEROSCOPE, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR SEMI- RIGID URETEROSCOPE, BY COUNTRY 2021-2031(%)
  • FIGURE 13. URETEROSCOPY MARKET, BY APPLICATION, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR UROLITHIASIS, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR KIDNEY CANCER, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR URINARY STRICTURE, BY COUNTRY 2021-2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 18. URETEROSCOPY MARKET, BY END USER, 2021(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR HOSPITALS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF URETEROSCOPY MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 22. URETEROSCOPY MARKET BY REGION, 2021
  • FIGURE 23. U.S. URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. CANADA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. MEXICO URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. GERMANY URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. FRANCE URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. UK URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. ITALY URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. SPAIN URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. REST OF EUROPE URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. JAPAN URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. CHINA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. AUSTRALIA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. INDIA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. SOUTH KOREA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. REST OF ASIA-PACIFIC URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. BRAZIL URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SAUDI ARABIA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. SOUTH AFRICA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. REST OF LAMEA URETEROSCOPY MARKET, 2021-2031 ($MILLION)
  • FIGURE 42. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 43. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 44. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 45. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 46. COMPETITIVE DASHBOARD
  • FIGURE 47. COMPETITIVE HEATMAP: URETEROSCOPY MARKET
  • FIGURE 48. TOP PLAYER POSITIONING, 2021
  • FIGURE 49. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 50. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 51. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 52. OLYMPUS CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 53. OLYMPUS CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 54. OLYMPUS CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 55. HOYA CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 56. HOYA CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 57. STERIS PLC: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 58. STERIS PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 59. STERIS PLC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 60. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 61. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
目次
Product Code: A11013

The global ureteroscopy market was valued at $807.34 million in 2021, and is projected to reach $1,379.82 million by 2031, registering a CAGR of 5.5% from 2022 to 2031.  

Ureteroscopy is a procedure used to diagnose and treat a wide range of urinary tract issues. A tiny scope (like flexible telescope) is introduced into the bladder and ureter. Ureteroscopy is an examination of the upper urinary tract and performed with an ureteroscope which is inserted directly into the ureter after passing through the urethra and bladder. This procedure is useful in the diagnosis and treatment of disorders such as kidney stones and urothelial carcinoma of the upper urinary tract. The procedure typically takes one to three hours to complete and is usually done while the patient is under general anesthesia.  

The growth of the global ureteroscopy market is majorly driven by rise in technological advancement and increase in prevalence of urological diseases such as kidney cancer and kidney stone that require ureteroscopy devices and are the major factors that boost the market growth. Furthermore, increased medical demands in the developing countries such as India and China and growth opportunities in emerging markets are expected to create immense opportunities for the ureteroscopy market during the forecast period. 

However, the high cost associated with the ureteroscopes hinders the growth of the market. Moreover, clinical barriers for ureteroscopes and risk of infection act as major restraints for the global ureteroscopy market. Conversely, increase in healthcare expenditure and rise in number of specialized hospitals & clinics in countries such as China and India are expected to create lucrative opportunities for the growth of the market. 

The global ureteroscopy market is segmented into product, application, end user, and region. By product, the market is categorized into flexible ureteroscope and semi-rigid ureteroscope. On the basis of application, the market is segregated into urolithiasis, kidney cancer, urinary stricture, and others. According to end user, the market is classified into hospitals, ambulatory surgical centers, and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). 

Major key players that operate in the global ureteroscopy market are: Advin Health Care, Boston Scientific Corporation, Cliniva Healthcare, Hoya Corporation, KARL STORZ SE & Co. KG, Olympus Corporation, OTU Medical, Richard Wolf GmbH, STERIS plc, and Stryker Corporation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the ureteroscopy market analysis from 2021 to 2031 to identify the prevailing ureteroscopy market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the ureteroscopy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global ureteroscopy market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Flexible Ureteroscope
  • Semi- Rigid Ureteroscope

By Application

  • Urolithiasis
  • Kidney Cancer
  • Urinary Stricture
  • Others

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • KARL STORZ SE & Co. KG
  • Hoya Corporation
  • Stryker Corporation
  • Boston Scientific Corporation
  • Advin Health Care
  • Cliniva Healthcare
  • Olympus Corporation
  • OTU Medical
  • Richard Wolf GmbH
  • STERIS plc

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. High bargaining power of suppliers
    • 3.3.2. High bargaining power of buyers
    • 3.3.3. High threat of substitutes
    • 3.3.4. High threat of new entrants
    • 3.3.5. Moderate intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in prevalence of urological diseases
      • 3.4.1.2. Increase in number of urological surgeries
      • 3.4.1.3. Increase in demand for ureteroscopes
    • 3.4.2. Restraints
      • 3.4.2.1. Side effects of ureteroscopes
      • 3.4.2.2. High cost of digital ureteroscopes
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in technological advancements
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: URETEROSCOPY MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Flexible Ureteroscope
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Semi- Rigid Ureteroscope
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: URETEROSCOPY MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Urolithiasis
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Kidney Cancer
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Urinary Stricture
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
  • 5.5. Others
    • 5.5.1. Key market trends, growth factors and opportunities
    • 5.5.2. Market size and forecast, by region
    • 5.5.3. Market share analysis by country

CHAPTER 6: URETEROSCOPY MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospitals
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Ambulatory Surgical Centers
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: URETEROSCOPY MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Product
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Product
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Product
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Product
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Product
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Product
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Product
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Product
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Product
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Product
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Product
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. Australia
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Product
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. India
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Product
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Product
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Product
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Product
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Product
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Product
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Product
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Advin Health Care
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
  • 9.2. Boston Scientific Corporation
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. Cliniva Healthcare
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. KARL STORZ SE & Co. KG
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
  • 9.5. Olympus Corporation
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. OTU Medical
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. Hoya Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. Richard Wolf GmbH
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. STERIS plc
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. Stryker Corporation
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance